These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20333397)

  • 1. Preanalytical variability: the dark side of the moon in blood doping screening.
    Lippi G; Banfi G; Maffulli N
    Eur J Appl Physiol; 2010 Jul; 109(5):1003-5. PubMed ID: 20333397
    [No Abstract]   [Full Text] [Related]  

  • 2. The science of doping.
    Berry DA
    Nature; 2008 Aug; 454(7205):692-3. PubMed ID: 18685682
    [No Abstract]   [Full Text] [Related]  

  • 3. Doping: world agency sets standards to promote fair play.
    Ljungqvist A; Horta L; Wadler G
    Nature; 2008 Oct; 455(7217):1176. PubMed ID: 18971999
    [No Abstract]   [Full Text] [Related]  

  • 4. [Doping control in sports].
    Ueki M
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():356-9. PubMed ID: 15658337
    [No Abstract]   [Full Text] [Related]  

  • 5. Doping: a paradigm shift has taken place in testing.
    Sottas PE; Saudan C; Saugy M
    Nature; 2008 Sep; 455(7210):166. PubMed ID: 18784700
    [No Abstract]   [Full Text] [Related]  

  • 6. Doping: using flexible criteria could reduce false positives.
    Faber NM
    Nature; 2008 Oct; 455(7217):1176. PubMed ID: 18972000
    [No Abstract]   [Full Text] [Related]  

  • 7. The faking of champions.
    DeFrancesco L
    Nat Biotechnol; 2004 Sep; 22(9):1069-71. PubMed ID: 15340461
    [No Abstract]   [Full Text] [Related]  

  • 8. Preanalytical phase of soluble receptor of transferrin.
    Banfi G
    Int J Sports Med; 2007 Jan; 28(1):88-9. PubMed ID: 17203438
    [No Abstract]   [Full Text] [Related]  

  • 9. Preanalytical mixing of whole-blood specimens in the context of the Athlete Passport.
    Ashenden M; Clarke A; Sharpe K; d'Onofrio G; Allbon G; Gore CJ
    J Clin Pathol; 2012 Jan; 65(1):8-13. PubMed ID: 22049219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nandrolone Progress Report to the UK Sports Council from the Expert Committee on Nandrolone February 2003.
    Callicott R; Kicman AT;
    Int J Sports Med; 2003 Nov; 24(8):620-6. PubMed ID: 14598200
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug testing at the Sydney Olympics.
    Corrigan B; Kazlauskas R
    Med J Aust; 2000 Sep; 173(6):312-3. PubMed ID: 11061402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second generation blood tests to detect erythropoietin abuse by athletes: effective but not preventive?
    Lippi G; Franchini M; Guidi G
    Haematologica; 2004 Apr; 89(4):ELT05. PubMed ID: 15075118
    [No Abstract]   [Full Text] [Related]  

  • 13. New drugs and methods of doping and manipulation.
    Thevis M; Kohler M; Schänzer W
    Drug Discov Today; 2008 Jan; 13(1-2):59-66. PubMed ID: 18190865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haematological testing and antidoping policies - Re: Robinson N, Schattenberg L, Zorzoli M, Mangin P, Saugy M. Haematological analysis conducted at the departure of the Tour de France 2001. Int J Sports Med 2005; 26: 200-207.
    Lippi G; Franchini M; Guidi GC
    Int J Sports Med; 2005; 26(6):508-9; author reply 510-1. PubMed ID: 16037898
    [No Abstract]   [Full Text] [Related]  

  • 15. Reference standards to underpin the detection of steroid abuse by athletes.
    Mackay LG
    Anal Bioanal Chem; 2008 Jun; 391(3):911-3. PubMed ID: 18278486
    [No Abstract]   [Full Text] [Related]  

  • 16. Future of the fight against doping: risk assessment, biological profiling and intelligence testing.
    Saugy M; Robinson N; Grimm K; Dvorak J
    Forensic Sci Int; 2011 Dec; 213(1-3):1-2. PubMed ID: 21835567
    [No Abstract]   [Full Text] [Related]  

  • 17. A level playing field?
    Nature; 2008 Aug; 454(7205):667. PubMed ID: 18685647
    [No Abstract]   [Full Text] [Related]  

  • 18. Globalisation of anti-doping: the reverse side of the medal.
    Kayser B; Smith AC
    BMJ; 2008 Jul; 337(7661):a584. PubMed ID: 18614466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fight for fair play.
    Honour JW
    Nature; 2004 Jul; 430(6996):143-4. PubMed ID: 15241389
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of continuous erythropoietin receptor activator in blood and urine in anti-doping control.
    Lasne F; Martin L; Martin JA; de Ceaurriz J
    Haematologica; 2009 Jun; 94(6):888-90. PubMed ID: 19483162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.